237 related articles for article (PubMed ID: 38097199)
1. The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies.
Redondo J; Bailey S; Kemp KC; Scolding NJ; Rice CM
Stem Cells Transl Med; 2024 Mar; 13(3):219-229. PubMed ID: 38097199
[TBL] [Abstract][Full Text] [Related]
2. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
3. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.
Strioga M; Viswanathan S; Darinskas A; Slaby O; Michalek J
Stem Cells Dev; 2012 Sep; 21(14):2724-52. PubMed ID: 22468918
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells.
Nguyen LT; Hoang DM; Nguyen KT; Bui DM; Nguyen HT; Le HTA; Hoang VT; Bui HTH; Dam PTM; Hoang XTA; Ngo ATL; Le HM; Phung NY; Vu DM; Duong TT; Nguyen TD; Ha LT; Bui HTP; Nguyen HK; Heke M; Bui AV
Stem Cells Transl Med; 2021 Sep; 10(9):1266-1278. PubMed ID: 34080789
[TBL] [Abstract][Full Text] [Related]
5. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
7. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
Chun S; Choi CB; Kim MS; Nam JY; Lee TY; Lee YT; Kim S; Han SB; Bae SC
Lupus; 2022 Sep; 31(10):1245-1253. PubMed ID: 35802867
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?
Azizi Z; Abbaszadeh R; Sahebnasagh R; Norouzy A; Motevaseli E; Maedler K
Stem Cell Res Ther; 2022 Jul; 13(1):348. PubMed ID: 35883121
[TBL] [Abstract][Full Text] [Related]
10. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
Wang J; Liao L; Wang S; Tan J
Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
14. Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis.
Loisel S; Lansiaux P; Rossille D; Ménard C; Dulong J; Monvoisin C; Bescher N; Bézier I; Latour M; Cras A; Farge D; Tarte K
Stem Cells Transl Med; 2023 Apr; 12(4):194-206. PubMed ID: 36928395
[TBL] [Abstract][Full Text] [Related]
15. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.
Gorodetsky R; Aicher WK
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069909
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy.
van de Vyver M
Stem Cells Dev; 2017 Jul; 26(14):1042-1053. PubMed ID: 28447876
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
18. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal progenitor cells in red and yellow bone marrow.
Gurevitch O; Slavin S; Resnick I; Khitrin S; Feldman A
Folia Biol (Praha); 2009; 55(1):27-34. PubMed ID: 19445844
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
